Company attributes
Industry
B2X
Founder
Legal Name
Vectalys SAS
Date Incorporated
December 23, 2019
Spinout
Number of Employees (Ranges)
11 – 50
Phone Number
+33561287075
Full Address
Canal Biotech II, 3 rue des satellites, Toulouse, 31400, FR
Founded Date
January 1, 2005
Total Funding Amount (USD)
360,080
2,400,540
6,001,071
Latest Funding Round Date
2017
2016
Patents Assigned (Count)
2
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
1,080,045
60,002
1,800,075
Vectalys is the lentiviral manufacturing platform of Flash Therapeutics. The company specializes in lentiviral technology manufacturing with a record in vector design & production. Vectalys’ platform provides custom and premade lentiviral particles, for research and development purposes.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
